Cerevel Therapeutics to Report First Quarter 2021 Financial Results on Monday, May 17, 2021
CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced it will report first quarter 2021 financial results on Monday, May 17, 2021, before the U.S. financial markets open.
Management will host a conference call to discuss first quarter 2021 financial results and recent business updates on Monday, May 17, 2021 at 8:00 a.m. EDT. To access the call, please dial 833-665-0655 (domestic) or 702-495-1044 (international) and refer to conference ID 4926779.
A live webcast of the call, along with supporting slides, will be available on the investors section of Cerevel’s website at investors.cerevel.com. Following the live webcast, an archived version of the call will be available on the website.
About Cerevel Therapeutics
Special Note Regarding Forward-Looking Statements
Conference Sessions (Full conference pass required)
Keynote Presentation by Zoom
AI Use Case